Gilead Sciences, Inc. (GILD) Guidance & Earnings Results
On 2026-05-07 Gilead Sciences, Inc. raised guidance: "Full-year revenue guidance…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
GILDGilead Sciences, Inc.Follow GILD — free
—
Price chart with a free account
- Market cap
- 193.5B
- P/E TTM
- —
- Dividend yield
- 2.1%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 7 May 26 | Raised | Full-year revenue guidance raised · full year |
| 7 Aug 25 | Raised | FY2025 revenue and EPS guidance raised; specific numbers not provided in excerpt. · full year |
Gilead Sciences, Inc. — questions
- What guidance did Gilead Sciences, Inc. give?
- On 2026-05-07: "Full-year revenue guidance raised"
- When does Gilead Sciences, Inc. report earnings?
- Gilead Sciences, Inc.'s next earnings report is expected on 2026-10-29.
Every figure on this page comes from Gilead Sciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.